Tissue calcium in uraemia.

The content of calcium in the thoracic aorta, the heart and the kidney was determined in rats with moderate renal failure treated with 1.25-dihydroxycholecalciferol (1.25-DHCC) 100 ng/kg/day and Verapamil 20 mg/kg/day. In the aorta the content of calcium was significantly increased in uraemic rats and this increase was significantly augmented after administration of 1.25-DHCC. In the kidney no increase in calcium was seen in rats with uraemia, but treatment with 1.25-DHCC increased the calcium content significantly. This increase was not correlated to the serum calcium x phosphate product, which was almost normal. In the heart no changes in the content of calcium were observed. Verapamil did not influence the effect of 1.25-DHCC. It is concluded that administration of 1.25-DHCC per se may increase the content of calcium in the aorta and kidney in rats with moderate uraemia and possibly in this way sensitize the tissue to the development of tissue calcification.

[1]  E. Wilander,et al.  Tissue calcification and alkaline phosphatase activity in uraemic rats. , 1988, Scandinavian journal of urology and nephrology.

[2]  M. Goligorsky,et al.  Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. , 1985, Kidney international.

[3]  H. Johansson,et al.  The aortic content of glycosaminoglycans, hydroxyproline and calcium in experimental uraemia with special reference to parathyroidectomy and vitamin-D treatment. , 1984, Scandinavian journal of urology and nephrology.

[4]  T. Toda,et al.  THE ROLE OF 25‐HYDROXY‐VITAMIN D3 IN THE INDUCTION OF ATHEROSCLEROSIS IN SWINE and RABBIT BY HYPERVITAMINOSIS D , 1983, Acta pathologica japonica.

[5]  A. Frank,et al.  Selection of operating conditions and analytical procedure in multi-metal analysis of animal tissues by d.c. plasma-atomic emission spectroscopy , 1983 .

[6]  O. Ladefoged,et al.  Effect of 1 alpha-hydroxyvitamin D3 and dietary calcium and phosphate on the aortic mineral content in rabbits with mild azotemia. , 1983, Nephron.

[7]  E. Ogata,et al.  Evidence for acute inhibitory effects in vivo of 1 alpha-hydroxycholecalciferol on parathyroid hormone secretion in rats. , 1981, Endocrinology.

[8]  L. Ibels,et al.  Calcification in end-stage kidneys. , 1981, The American journal of medicine.

[9]  J. Kanis,et al.  The role of vitamin D metabolites in the osteomalacia of renal disease. , 1981, Current medical research and opinion.

[10]  S. Massry,et al.  Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy. , 1980, Kidney international.

[11]  A. Alfrey,et al.  Renal toxicity of phosphate in rats. , 1980, Kidney international.

[12]  Ibels Ls The pathogenesis of metastatic calcification in uraemia. , 1980 .

[13]  L. Ibels,et al.  Arterial calcification and pathology in uremic patients undergoing dialysis. , 1979, The American journal of medicine.

[14]  H. Johansson,et al.  Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy. , 1979, Scandinavian journal of urology and nephrology.

[15]  James H. Martin,et al.  Ultrastructure of calciphylaxis in skin , 1978 .

[16]  A. Norman,et al.  Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus. , 1977, The American journal of clinical nutrition.

[17]  A. Frank Automated wet ashing and multi-metal determination in biological materials by atomic-absorption spectrometry , 1976 .

[18]  J. Wergedal,et al.  Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. , 1975, The Journal of clinical investigation.

[19]  E. Bonucci,et al.  Dihydrotachysterol-induced aortic calcification. A histochemical and ultrastructural investigation. , 1975, Clinical orthopaedics and related research.

[20]  R. Humphreys,et al.  Physical biochemistry of calcification. , 1974, Clinical orthopaedics and related research.

[21]  Morrison Ab Experimentally induced chronic renal insufficiency in the rat. , 1962 .

[22]  D. Lehr,et al.  CAUSATIVE RELATIONSHIPS OF PARATHYROID HORMONE TO RENOGENIC AND RENIPRIVAL CARDIOVACULAR DISEASE , 1959, Annals of the New York Academy of Sciences.